172 related articles for article (PubMed ID: 37052688)
1. Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder.
During EH; Hernandez B; Miglis MG; Sum-Ping O; Hekmat A; Cahuas A; Ekelmans A; Yoshino F; Mignot E; Kushida CA
Sleep; 2023 Aug; 46(8):. PubMed ID: 37052688
[TBL] [Abstract][Full Text] [Related]
2. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.
Schenck CH; Montplaisir JY; Frauscher B; Hogl B; Gagnon JF; Postuma R; Sonka K; Jennum P; Partinen M; Arnulf I; Cochen de Cock V; Dauvilliers Y; Luppi PH; Heidbreder A; Mayer G; Sixel-Döring F; Trenkwalder C; Unger M; Young P; Wing YK; Ferini-Strambi L; Ferri R; Plazzi G; Zucconi M; Inoue Y; Iranzo A; Santamaria J; Bassetti C; Möller JC; Boeve BF; Lai YY; Pavlova M; Saper C; Schmidt P; Siegel JM; Singer C; St Louis E; Videnovic A; Oertel W
Sleep Med; 2013 Aug; 14(8):795-806. PubMed ID: 23886593
[TBL] [Abstract][Full Text] [Related]
3. Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial.
Roth T; Dauvilliers Y; Thorpy MJ; Kushida C; Corser BC; Bogan R; Rosenberg R; Dubow J; Seiden D
CNS Drugs; 2022 Apr; 36(4):377-387. PubMed ID: 35380374
[TBL] [Abstract][Full Text] [Related]
4. Sodium oxybate for idiopathic REM sleep behavior disorder: a report on two patients.
Moghadam KK; Pizza F; Primavera A; Ferri R; Plazzi G
Sleep Med; 2017 Apr; 32():16-21. PubMed ID: 28366329
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium oxybate, modafinil, and their combination on disrupted nighttime sleep in narcolepsy.
Dauvilliers Y; Roth T; Guinta D; Alvarez-Horine S; Dynin E; Black J
Sleep Med; 2017 Dec; 40():53-57. PubMed ID: 29221779
[TBL] [Abstract][Full Text] [Related]
6. Nelotanserin as symptomatic treatment for rapid eye movement sleep behavior disorder: a double-blind randomized study using video analysis in patients with dementia with Lewy bodies or Parkinson's disease dementia.
Stefani A; Santamaria J; Iranzo A; Hackner H; Schenck CH; Högl B
Sleep Med; 2021 May; 81():180-187. PubMed ID: 33714847
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of REM sleep behavior disorder with sodium oxybate.
Shneerson JM
Clin Neuropharmacol; 2009; 32(3):158-9. PubMed ID: 19483483
[TBL] [Abstract][Full Text] [Related]
8. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
Dauvilliers Y; Šonka K; Bogan RK; Partinen M; Del Rio Villegas R; Foldvary-Schaefer N; Skowronski R; Chen A; Black J; Skobieranda F; Thorpy MJ
CNS Drugs; 2022 Jun; 36(6):633-647. PubMed ID: 35635687
[TBL] [Abstract][Full Text] [Related]
9. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR
JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.
Lecendreux M; Plazzi G; Dauvilliers Y; Rosen CL; Ruoff C; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
J Clin Sleep Med; 2022 Sep; 18(9):2217-2227. PubMed ID: 35689598
[TBL] [Abstract][Full Text] [Related]
11. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study.
Russell JI; Holman AJ; Swick TJ; Alvarez-Horine S; Wang GY; Guinta D;
Pain; 2011 May; 152(5):1007-1017. PubMed ID: 21397402
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
Bogan RK; Foldvary-Schaefer N; Skowronski R; Chen A; Thorpy MJ
CNS Drugs; 2023 Apr; 37(4):323-335. PubMed ID: 36947322
[TBL] [Abstract][Full Text] [Related]
13. Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
Kushida CA; Shapiro CM; Roth T; Thorpy MJ; Corser BC; Ajayi AO; Rosenberg R; Roy A; Seiden D; Dubow J; Dauvilliers Y
Sleep; 2022 Jun; 45(6):. PubMed ID: 34358324
[TBL] [Abstract][Full Text] [Related]
14. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
Black J; Swick T; Bogan R; Lai C; Carter LP
Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
[TBL] [Abstract][Full Text] [Related]
15. Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis.
Alshaikh MK; Tricco AC; Tashkandi M; Mamdani M; Straus SE; BaHammam AS
J Clin Sleep Med; 2012 Aug; 8(4):451-8. PubMed ID: 22893778
[TBL] [Abstract][Full Text] [Related]
16. Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsy.
Husain AM; Bujanover S; Ryan R; Scheckner B; Black J; Profant J
J Clin Sleep Med; 2020 Sep; 16(9):1469-1474. PubMed ID: 32356515
[TBL] [Abstract][Full Text] [Related]
17. Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial.
Gilat M; Coeytaux Jackson A; Marshall NS; Hammond D; Mullins AE; Hall JM; Fang BAM; Yee BJ; Wong KKH; Grunstein RR; Lewis SJG
Mov Disord; 2020 Feb; 35(2):344-349. PubMed ID: 31674060
[TBL] [Abstract][Full Text] [Related]
18. Clonazepam for probable REM sleep behavior disorder in Parkinson's disease: A randomized placebo-controlled trial.
Shin C; Park H; Lee WW; Kim HJ; Kim HJ; Jeon B
J Neurol Sci; 2019 Jun; 401():81-86. PubMed ID: 31035190
[TBL] [Abstract][Full Text] [Related]
19. Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy.
Dauvilliers Y; Lammers GJ; Lecendreux M; Maski K; Kansagra S; Black J; Parvataneni R; Chen A; Wang YG; Plazzi G
J Clin Sleep Med; 2024 Mar; 20(3):445-454. PubMed ID: 37942930
[TBL] [Abstract][Full Text] [Related]
20. REM Sleep Behavior Disorder in Children With Type 1 Narcolepsy Treated With Sodium Oxybate.
Antelmi E; Filardi M; Pizza F; Vandi S; Moresco M; Franceschini C; Tinazzi M; Ferri R; Plazzi G
Neurology; 2021 Jan; 96(2):e250-e254. PubMed ID: 33177222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
